HomeInsightsMarket Capitalization

Market Capitalization of Bafna Pharmaceuticals Ltd

Market Capitalization of Bafna Pharmaceuticals Ltd

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

0.0 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Bafna Pharmaceuticals Ltd

NSE: BAFNAPH

Market Cap

₹ 189.25 crore

Last updated on: Nov 22, 2024

Key Highlights

  • The Market Cap of Bafna Pharmaceuticals Ltd is ₹ 189.25 crore as of 22 Nov 24 .
  • The Market Cap of Bafna Pharmaceuticals Ltd changed from ₹ 25.9 crore on March 2019 to ₹ 2.1 crore on March 2020 . This represents a CAGR of -71.53% over 2 years.
  • The Latest Trading Price of Bafna Pharmaceuticals Ltd is ₹ 80 as of 22 Nov 15:30 .

Historical Market Cap of Bafna Pharmaceuticals Ltd

No data available

* All values are in crore

Company Fundamentals for Bafna Pharmaceuticals Ltd

No data available

Image

Bafna Pharmaceuticals Ltd

NSE: BAFNAPH

Share Price

₹ 80

0.00 (0.00%)

stock direction

Last updated on: Nov 22, 2024

Market Price of Bafna Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Bafna Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 202480
21 Nov 202480
14 Nov 202480.03
12 Nov 202480.03
11 Nov 202484.17
08 Nov 202481.9
07 Nov 202482
06 Nov 202479.45
28 Oct 202477
25 Oct 202480.94

SWOT Analysis Of Bafna Pharmaceuticals Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Bafna Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Bafna Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Bafna Pharmaceuticals Ltd

No data available

No data available

Historical P/E Ratio of Bafna Pharmaceuticals Ltd

No data available

* All values are in %

Historical Revenue of Bafna Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Bafna Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Bafna Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

About Bafna Pharmaceuticals Ltd

  • Bafna Pharmaceuticals Limited (BPL) was started as a proprietary concern in 1981 by Mr. Bafna Mahaveer Chand in the name of Bafna Pharmaceutical and has been engaged in the business of manufacturing pharmaceutical formulations of Betalactum and Non Betalactum products.
  • The first manufacturing unit was set up at Madhavaram (Chennai) during October 1984 for manufacture of tablets with an installed capacity of 420 lacs tablets p.a.
  • Subsequently the capsule line was added during 1987 with a capacity of 300 lacs capsule p.a. and then liquid line with an installed capacity of 45000 lts p.a was added in 1990. Bafna Pharmaceuticals, incorporated in 1995, had acquired the entire business of the proprietary concern.
  • During the year 2001, the company constructed a separate block at Madhavaram for manufacturing Betalactum products.

Bafna Pharmaceuticals Ltd News Hub

News

Bafna Pharmaceuticals to discuss results

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 11 N...

Read more

04 Nov 202418:39

News

Bafna Pharmaceuticals schedules AGM

Bafna Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will ...

Read more

05 Sep 202410:29

News

Bafna Pharmaceuticals to convene AGM

Bafna Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will ...

Read more

04 Sep 202417:49

News

Bafna Pharmaceuticals to declare Quarterly Result

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 A...

Read more

10 Aug 202413:56

News

Bafna Pharmaceuticals to hold board meeting

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 M...

Read more

28 May 202413:49

News

Bafna Pharmaceuticals to declare Quarterly Result

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 F...

Read more

03 Feb 202414:11

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Bafna Pharmaceuticals Ltd Market Cap

What is the market cap of Bafna Pharmaceuticals Ltd?

As of November 23, 2024, Bafna Pharmaceuticals Ltd has a market capitalization of ₹189.25, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Bafna Pharmaceuticals Ltd's market capitalization?

Bafna Pharmaceuticals Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Bafna Pharmaceuticals Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Bafna Pharmaceuticals Ltd's market capitalization change?

Bafna Pharmaceuticals Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*